Reuters logo
BRIEF-PTC Therapeutics qtrly loss per share $0.85
May 8, 2017 / 11:47 AM / 5 months ago

BRIEF-PTC Therapeutics qtrly loss per share $0.85

May 8 (Reuters) - PTC Therapeutics Inc:

* Qtrly loss per share $0.85

* Qtrly total revenues $26,5 million versus $18.9 million

* PTC Therapeutics Inc - translarna net sales for 2017 are now anticipated to be between $115 and $130 million

* PTC Therapeutics Inc -GAAP operating expenses for full year 2017 are anticipated to be between $250 to $260 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below